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Loss of Integrin a9b1 Results in Defects in
Proliferation, Causing Poor Re-Epithelialization
during Cutaneous Wound Healing
Purva Singh1,4, Chun Chen2,4, Sonali Pal-Ghosh3, Mary Ann Stepp3, Dean Sheppard2 and
Livingston Van De Water1
The wound microenvironment comprises constituents, such as the extracellular matrix (ECM), that regulate with
temporal and spatial precision, the migratory, proliferative, and contractility of wound cells. Prompt closure of
the wound is an early and critical phase of healing and b1 integrins are important in this process. We previously
reported a marked increase in integrin a9b1 expression in epidermal keratinocytes in cutaneous and corneal
wounds. However, the functional role of keratinocyte a9b1 during re-epithelialization is unknown and analysis
has been precluded by the lethal phenotype of integrin a9b1 knockout mice. We now report that in conditional
integrin a9 knockout (K14-a9 null) mice, normal proliferation occurs in epidermal keratinocytes and corneal
basal cells. Normal epidermal keratinocyte morphology is also retained. However, corneal basal cell
morphology and epithelial thickness are altered, suggesting that loss of integrin a9b1 results in abnormal
corneal differentiation. In cutaneous wounds, the number of proliferating epidermal keratinocytes is
significantly reduced in K14-a9 null mice compared with a9fl/ mice, but not in Cre (control) mice. The
decreased keratinocyte proliferation observed in K14-a9 null mice negatively impacts healing, resulting in a
thinner migrating epithelium, demonstrating that a9b1 is crucial for efficient and proper re-epithelialization
during cutaneous wound healing.
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INTRODUCTION
Re-epithelialization is essential for successful wound healing
and requires contributions from keratinocyte proliferation,
migration, and differentiation. Integrins and their interaction
with the ligand(s) in the provisional matrix and ECM are one
of the key regulators of keratinocyte function (Martin, 1997;
Singer and Clark, 1999). Defects in one or multiple
keratinocyte function(s) can have pleiotropic effects, ranging
from excessive scarring to the formation of chronic ulcers.
In the normal epidermis, the integrin heterodimer
repertoire is mainly restricted to the basal keratinocyte
and prominently includes a2b1, a3b1, a5b1 , a9b1, avb6,
and a6b4 (Hertle et al., 1991; Larjava et al., 1993;
Palmer et al., 1993; Stepp and Zhu, 1997; Stepp et al.,
2002). Integrin a3b1 and a6b4 bind to the basement
membrane component laminin-5 (DiPersio et al., 1997;
Nguyen et al., 2000; Choma et al., 2004; Frank and
Carter, 2004). Integrin a2b1 recognizes collagen (I and IV)
and some forms of laminin (Grenache et al., 2007;
Parks, 2007; Zweers et al., 2007). Integrin a5b1 and avb6
are fibronectin (FN) receptors; avb6 also bind to tenascin-C
(Larjava et al., 1993; Yang et al., 1993; AlDahlawi et al.,
2006). Integrin a9b1 is normally expressed in airway
epithelial cells, the basal layer of squamous epithelia, smooth
muscle, skeletal muscle, neutrophils, and hepatocytes
(Palmer et al., 1993; Taooka et al., 1999). ECM ligands for
integrin a9b1 include tenascin-C, osteopontin, vascular cell
adhesion molecule-1, disintegrin and metalloproteases-12
and 15, and the EIIIA segment of FN (Yokosaki et al., 1994,
1996, 1999; Taooka et al., 1999; Eto et al., 2000; Liao et al.,
2002; Shinde et al., 2008). In stratified squamous epithelial
cells on the healthy ocular surface, a9 integrin expression is
restricted to a subset of basal cells at the limbus (Stepp
and Zhu, 1997) where it has also been shown to be expressed
on the early transiently amplifying cells adjacent to the
corneal epithelial stem cell niche (Pajoohesh-Ganji and
Stepp, 2005).
& 2009 The Society for Investigative Dermatology www.jidonline.org 217
ORIGINAL ARTICLE
Received 21 December 2007; revised 13 March 2008; accepted 22 April
2008; published online 17 July 2008
1Center for Cell Biology and Cancer Research, Albany Medical College,
Albany, New York, USA; 2Lung Biology Center, Department of Medicine,
University of California, San Francisco, California, USA and 3Department of
Anatomy and Regenerative Biology, George Washington University Medical
Center, Washington, District Columbia, USA
Correspondence: Dr Livingston Van De Water, Center for Cell Biology and
Cancer Research (MC-165), Albany Medical College, 47 New Scotland
Avenue, Albany, New York 12208, USA.
E-mail: vandewl@mail.amc.edu
4These authors contributed equally to this work
Abbreviations: ECM, extracellular matrix; ES, embryonic stem; FN,
fibronectin; FRT, Flp recombinase target; K14, keratin 14; PBS, phosphate-
buffered saline
Integrin expression and functional profiles on keratinocyte
changes after injury. Integrin heterodimers, upregulated after
wounding, include a3b1, a2b1, a5b1, a9b1, avb6, avb5, and
a6b4, suggesting that integrins have specific as well as
redundant functions during wound repair (Hertle et al., 1991;
Larjava et al., 1993; Hakkinen et al., 2000; Singh et al., 2004;
Raymond et al., 2005; Zweers et al., 2007). However, the
precise function(s) for individual integrin heterodimers during
wound healing in vivo remains unclear.
Conditional ablation of integrin b1 in skin causes defective
hair follicle invagination into the dermis and decreased
proliferation and differentiation of the keratinocytes (Fassler
and Meyer, 1995; Raghavan et al., 2000; Brakebusch et al.,
2002; Grose et al., 2002). After injury, b1 null mice exhibit seve-
rely impaired re-epithelialization (Grose et al., 2002). However,
the roles of each a-chain partner required along with b1 to
mediate these functions are not clearly understood. Integrin
a3b1 knockout mice display a neonatal lethal phenotype,
including severe epidermal blistering and defects in basement
membrane organization, and integrin a3b1 regulates keratino-
cyte migration on a laminin 322-rich matrix and the deposition
of laminin 322 (DiPersio et al., 1997; Choma et al., 2004; Frank
and Carter, 2004). However, the precise function of integrin
a3b1 during wound healing remains unclear.
Integrin a5b1 null mice exhibit an embryonic lethal
phenotype, and the functional role of a5b1 during cutaneous
wound healing remains unknown (Yang et al., 1993).
Surprisingly, skin-specific knockout of either a2b1 or a6b4
had no effect on the re-epithelialization process during
cutaneous wound healing (Raymond et al., 2005; Grenache
et al., 2007; Parks, 2007; Zweers et al., 2007). Similarly, no
wound healing defects were observed in avb5 knockout mice
(Huang et al., 2000a). However, integrin avb6 null mice
exhibit age-dependent defects in wound healing (AlDahlawi
et al., 2006). Taken together, these data suggest that integrins
have redundant functions to ensure efficient and prompt re-
epithelialization, and eliminating any single integrin hetero-
dimer does not completely impair the process.
We have previously reported that integrin a9b1 expression
is elevated from day 1 through day 7 after injury and
decreases thereafter between days 10 and 14 in epidermal
keratinocytes (Singh et al., 2004). The localization of integrin
a9b1 to the margins of sealing corneal epithelia sheets just
before wound closure suggests additional roles for a9b1 in
mediating cell–cell adhesion in closing wounds (Stepp and
Zhu, 1997; Hakkinen et al., 2000; Stepp et al., 2002).
Although the identity of the ligand(s) for keratinocyte a9b1 is
unknown, tenascin-C and EIIIAþ FN are prominently
expressed beneath the migrating epidermis (Mackie et al.,
1988; Stepp and Zhu, 1997; Singh et al., 2004). Upregulation
of integrin a9b1 expression during wound healing suggests
that it is a critical contributor to the re-epithelialization
process. In vitro studies have shown that integrin a9b1
promotes proliferation and migration of colon carcinoma
cells on tenascin-C (Yokosaki et al., 1996; Young et al., 2001;
Chen et al., 2004). However, analyses of wound keratinocyte
a9b1 functions have been hampered by the loss of a9b1 from
primary keratinocytes in culture (unpublished) and by the
neonatal lethal phenotype of integrin a9b1 knockout mice
(Huang et al., 2000b).
To overcome these limitations, we developed a genetic
approach using a Cre–LoxP recombination system to remove
integrin a9b1 from the skin and cornea. These integrin a9
knockout mice were generated by crossing mice homozygous
for a floxed a9 allele (a9fl/fl) with mice heterozygous for a9
and K14 Cre transgene (a9þ /; K14 Creþ /). K14-a9 null
mice were viable and showed no obvious defects in skin
morphology. However, normal cell morphology was altered
in both the central and limbal regions of the eye. After
cutaneous injury, interfollicular epidermal keratinocyte
proliferation was decreased in K14-a9 null mice compared
with control mice but epidermal migration remained
unaffected. The decreased keratinocyte proliferation in K14-
a9 null wound negatively influenced the re-epithelialization
process, thereby affecting the overall quality of re-epithelia-
lization.
RESULTS
Generation of K14-a9 null mice
We chose to use a conditional genetic approach to inactivate
the a9 gene (Huang et al., 2000b). An integrin a9 floxed
targeting vector was designed to delete exon 8 within the a9
gene (Figure 1a). Correctly targeted embryonic stem cells
were injected into blastocysts giving rise to two independent
lines of chimeric mice. These were backcrossed into C57Bl/6
mice, and the neomycin selection marker was removed by
crossing with Flpe transgenic mice to generate integrin a9fl/fl
mice. The a9fl/fl mice were viable and appeared normal,
suggesting that insertion of lox P sites did not alter the
function of the a9 subunit. To generate conditional knockout
of the a9 gene in the skin and corneal epithelial cells, we
crossed a9fl/fl mice with a9þ /; K14 Creþ / mice and
obtained the expected genotypes (Figure 1b). We confirmed
by genomic PCR on tail DNA of adult mice the presence of
the floxed and/or wild-type alleles, as well as removal of the
floxed a9 exon following K14 Cre-mediated recombination
(Figure 1c). In some instances, a faint band representing the
floxed allele was detected in the tail DNA of K14-a9 null
mice, but the cleaved a9 was more predominant.
Loss of integrin a9 from the epidermis and corneal epithelial
cells
Integrin a9b1 is expressed in the basal layer of keratinocytes
in the unwounded skin and by a subset of basal cells at the
periphery of the cornea in the limbus (Palmer et al., 1993;
Stepp and Zhu, 1997; Stepp et al., 2002; Singh et al., 2004).
To validate the effective knockout of integrin a9 by K14
Cre-mediated recombination in the skin and cornea, the
unwounded skin sections or whole mount corneas isolated
either from K14-a9 null or from control mice were used. We
observed complete loss of a9 staining in basal keratinocytes
of the unwounded skin of K14-a9 null mice (Figure 2a–h).
Similarly, using a whole cornea flat mount immunofluor-
escent confocal microscopy approach, we confirmed the loss
of a9 from corneal epithelial cells in K14-a9 null mice (Figure
2i and j). These observations established complete knockout
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of a9 in epidermal keratinocytes and in corneal epithelial
cells.
Characterization of the uninjured skin and cornea in K14-a9
null mice
Skin. To investigate if conditional knockout of a9 affects
normal skin keratinocyte morphology or organization,
unwounded skin biopsies isolated from either K14-a9 null
or control mice were embedded either in plastic or paraffin.
Sections of 5 mm or 1 mm were prepared and stained with
hematoxylin and eosin stain (Figure 3a and b) or Giemsa
stain (Figure 3c and d), and no apparent difference in the
organization of keratinocytes or morphology was observed in
the K14-a9 null skin compared with the control skin. To test
whether basal epidermal keratinocytes cell proliferation
in vivo was affected in the K14-a9 null skin, we performed
Ki67 labeling studies. In the normal skin, 11–15% of the
interfollicular keratinocyte was labeled with Ki67 in both
K14-a9 null and control skin, indicating that resting
keratinocyte proliferation is not affected in K14-a9 null mice
(data not shown).
Cornea. On gross examination, no differences were seen in
eye size or corneal clarity (Figure 3e and f). Flat mounts of
control and K14-a9 null corneas were used to visualize
the localization of E-cadherin and nuclei (propidium iodide)
and three-dimensional image reconstructions were generated
by confocal microscopy and image analysis. Representative
en face (Figure 3g and i) and cross-sectional views
of 120120mm sections (Figure 3h and j) through the
entire thickness of control and K14-a9 null mouse corneas,
respectively, are shown. The cross-sections show that control
corneas were B62 mm thick (entire z dimension, Figure 3h)
from the corneal endothelium to the epithelial apical
squames, and the corneal epithelial compartment thickness
was 14–15 mm and 3–5 cell layers (z above dotted line,
Figure 3h). The K14-a9 null corneas were thinner at
B50 mm (entire z dimension, Figure 3j) and their epithelial
thickness was 11–13 mm (z dimension, above dotted line,
Figure 3j), but there appeared to be similar numbers of cell
layers. Further analysis showed that although the height
of the control basal cells was 4.5 mm, the K14-a9 null corneal
basal cells were significantly shorter at 3.3 mm (Figure 3k).
The area measurements of the basal cells show that the
corneal epithelial basal cells in the K14-a9 null mice were
significantly larger (B27%) than the control basal cells
(Figure 3g, h, and l). BrdU labeling results were normalized
to the observed area and this indicated that cell proliferation
in the K14-a9 null corneas was 33% less than controls
(Figure 3m–o). As the basal cells in the K14-a9 null corneas
are flatter and occupy more space on the corneal surface
than do control basal cells, the differences in basal cell
size (and number) negate the proliferation difference and
indicate that cell proliferation rates are similar in the
uninjured cornea and the skin of control and K14-a9 null
mice.
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Figure 1. Targeting strategy and molecular analysis of K14-a9 null mice. (a) Mouse integrin a9 locus, targeting vector and targeted allele. The upper
line shows a map of the a9 locus with the exon 8 defined by black boxes. The middle line shows targeting vector. The BamHI (b), XhoI (Xh), HindIII (H),
and NotI (N) restriction sites used for the generation and analysis of the construct as well as Neo (neomycin) and the TK (thymidine kinase). (b) Genotypes
obtained from crossing a9fl/fl mice with a9fl/; K14 Creþ / mice. (c) PCR analysis of tail genomic DNA, the conditional allele of the a9 gene was detected by
a9 primers (top panel) and the presence of Cre by Cre primers (bottom panel). PCR products were resolved by agarose gel electrophoresis and
visualized by ethidium bromide staining. Bands corresponding to the wild-type (wt) and floxed alleles (floxed) of the a9 gene as well as to the K14-Cre
transgene (Cre) were indicated. Sizes of molecular weight markers were indicated in base pairs (bp).
www.jidonline.org 219
P Singh et al.
A Role for Integrin a9b1 during Re-Epithelialization
Decreased keratinocytes proliferation in K14-a9 null mice
during cutaneous wound healing
Several studies have shown that after cutaneous injury,
keratinocytes proliferate to supply cells to the migrating
wound epidermis and yet the mechanisms regulating this are
unclear (Martin, 1997; Santoro and Gaudino, 2005). To
determine if the deletion of a9 from the skin affects wound
edge keratinocyte proliferation, we used Ki67 labeling and
BrdU incorporation, detected by immunostaining. Mice were
wounded and injected with BrdU, 4hours prior to harvest, at
intervals of 2, 4, and 7 days and the incorporation of BrdU in
interfollicular epidermal keratinocytes was determined. We
observed a 54% reduction in BrdU incorporation by day 2 and
up to 75% reduction by day 4 in interfollicular keratinocytes of
K14-a9 null wound sections compared with control wounds
(Figure 4a–f and quantified in panel g). At day 7, no significant
differences in BrdU incorporation were observed. The sections
stained for Ki67 antigen at days 2, 4, and 7 after wounding
showed no statistically significant difference in Ki67 labeling
of wound edge interfollicular keratinocytes at days 2 and 7.
However, a 40% decrease in Ki67 labeling was observed by
day 4 in K14-a9 null wounds compared with control wounds
(Figure 4h). Our data suggest that the loss of a9 impairs
proliferation of wound edge interfollicular keratinocytes,
before re-epithelialization. In addition, interfollicular keratino-
cytes residing behind the wound edges at day 2, after
wounding, showed a significant decrease in the proliferation
in the K14-a9 null skin compared with control skin (data not
shown). By contrast, no statistically significant differences
were observed in the proliferation of keratinocytes within hair
follicles in either K14-a9 null or control keratinocytes (data not
shown). The apparent discrepancy in Ki67 and BrdU labeling
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Figure 2. Effective knockout of a9 by K14-Cre mediated recombination in the skin and cornea. Unwounded skin (a–h) and cornea (i and j) were harvested
either from K14-a9 null or control mice. Harvested skin was oriented with the epidermis on the top and panniculus carnosus below. Unwounded consecutive
skin sections of K14-a9 null mice (a–d) or control mice (e–h) were treated either with rabbit anti-a9 (a, b, e, and f) or with K14 (c, d, g, and h) as a marker
for keratinocytes. No positive staining was detected for a9 in the epidermis (arrow) of K14-a9 null mice (a) when compared with the positive staining
observed for a9 in the control mice epidermis (e). Panels (b, d, f, and h) depict phalloidin staining of their corresponding panels (a, c, e, and g), respectively.
Using whole-mount confocal imaging, in the cornea, we confirm the loss of integrin a9 staining at the limbus of cornea in K14-a9 null mice (j) compared
with control mice (i). Dermis denoted as ‘D’; N¼3; scale bar: 50mm in panel (h) and 40 mm in panels (i and j).
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is likely due to the persistent expression of Ki67 in all phases of
cell cycle except G0, whereas BrdU labels only S-phase cells.
Our data suggest a defect in G1–S-phase entry, leading to a
delayed proliferation in K14-a9 null wound keratinocytes
compared with control wounds.
K14-a9 null cutaneous wounds re-epithelialize poorly
The process of re-epithelialization requires contributions
from both keratinocyte migration and proliferation to ensure
an efficient and proper closed wound. We hypothesized that
decreased interfollicular keratinocyte proliferation in K14-a9
null wounds would negatively affect the re-epithelialization
process. To analyze this, we performed quantitative morpho-
metric analysis of the migrating tongue at day 5 using two
parameters, length and area. The migrating tongue length
represents the distance traveled by the keratinocytes from the
wound edge to facilitate the process of re-epithelialization.
By contrast, the area of the wound edge represents the total
number of keratinocytes involved in the process of
re-epithelialization and is a function of keratinocyte pro-
liferation and cell size. It has been reported earlier that post-
injury cell size of keratinocytes is altered relative to the
uninjured epidermis (Coulombe, 2003). Although we also
observed this post-injury change, we did not observe any
apparent differences in the size of epidermal keratinocytes
within K14-a9 null wounds compared with control wounds.
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Figure 3. Histological differences in the cornea but not in the skin of unwounded K14-a9 null mice compared with controls. Images from control mice (a, c, e,
g, h, and m) and K14-a9 null mice (b, d, f, i, j, and n) were shown. Five micrometer paraffin (a and b)- or 1 mm plastic (c and d)-embedded sections of the
unwounded skin were stained with hematoxylin (H) and eosin (E) (a and b) or Giemsa stain (c and d). Arrows indicate epidermal keratinocytes. No differences in
organization or morphologies of keratinocytes were observed in K14-a9 null skin when compared with control skin. No differences were observed in gross
images of control and K14-a9 null mouse eyes (e and f). Cross-sectional representations generated from three-dimensional images of flat-mounted corneas
by confocal microscopy show that the K14-a9 null corneal epithelium is thinner than the control epithelium (g–j). The aqua dashed lines show the border
between the epithelial cells (above dotted line) and the stromal fibroblasts (below dotted line) in panels h and j. E-cadherin and propidium iodide (PI) stained en
face flat mounts (g and i) suggest that the K14-a9 null basal cells were flatter and that there were fewer cells per unit area on the corneal surface. The heights
of 10 basal cells were measured for both genotypes and show that the K14-a9 null basal cells were flatter than control basal cells (k). Areas were determined
from 70 and 63 control and K14-a9 null corneal epithelial basal cells, respectively, using Image Pro Plus software (g, i, l). Results confirm that the K14-a9 null
basal cells were flatter and more spread so that K14-a9 null mice haveB27% fewer epithelial basal cells on their cornea. BrdU labeling of the mouse corneas
were shown as flat mounts (m and n). Control (n¼ 7) and K14-a9 null (n¼ 7) corneas were quantified and presented normalized by area; fewer (B30%)
proliferating cells were observed in the K14-a9 null corneas compared with controls (o), because there are also fewer overall cells on the corneal surface,
taken together, these results indicate that the proliferation rates in the corneal surface and skin are similar. N¼ 3, scale bar: 50mm in panel (b), 20mm in
panel (d), 3 mm in panel (h and j), and 50mm in panel (n) (*Po0.05).
www.jidonline.org 221
P Singh et al.
A Role for Integrin a9b1 during Re-Epithelialization
Quantitative morphometric analysis enabled us to distinguish
between the contributions of proliferation from migration.
The length was measured from the wound edge to the tip of
the migrating tongue; the area was measured as the region
circumscribed by the newly synthesized epidermis over the
wound bed from the wound edge. We observed no difference
in the length of the migrating tongues of K14-a9 null wounds
compared with control wounds (Figure 5a–e). By contrast, we
observed a reduction in the area of the newly synthesized
epidermis covering the wound bed in K14-a9 null wounds
compared with the control wounds (Figure 5a–d and f). These
data suggest that migration is not impaired in K14-a9 null
cutaneous wounds, whereas decreased proliferation affects
the area of the migrating tongue.
By day 5 after wounding, merging of the wound edge
arising from opposite ends is normally completed. To further
evaluate whether migration remains unimpaired in K14-a9
null wounds compared with control wounds, we analyzed
5-day excisional wounds from the skin, harvested either from
K14-a9 null or from control mice. Determining the contribu-
tion of keratinocytes to resurface the wound by histological
analysis is often problematic due to the fact that wound sites
are asymmetrical and it can be difficult to bisect the wound
precisely. To ensure that we were comparing the same plane
of each wound section, we used a new method to measure
the distance traveled by the keratinocytes to close the wound
(see Materials and Methods). On quantitative analysis, no
statistically significant differences in the distance traveled by
the keratinocytes to close the wounds were observed in K14-
a9 null mice compared with control mice (Figure 5g). This
finding complements our above-mentioned observation, in
which the length of migrating tongue remains unaffected.
Thus, the rate of merging of wound edges, per se, is not
affected, whereas the area is affected. The decreased area of
the new synthesized epidermis of K14-a9 null wounds
appears to represent a compromised form of re-epithelializa-
tion in which efficient resurfacing is favored over quality and
suggests that this process is dictated, in part, by integrin a9b1.
Keratinocyte differentiation is disturbed, after cutaneous
injury in K14-a9 null mice
We next hypothesized that a thinner epithelium would delay
differentiation and we stained 7-, 10-, and 14-day cutaneous
wound sections either with rabbit anti-loricrin or with rabbit
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Figure 4. Decreased proliferation in wound edge keratinocytes of K14-a9 null mice compared with control mice. Excisional cutaneous wounds were
harvested at 4 days after wounding (a–f). Harvested wounds were oriented with the epidermis on top and the panniculus carnosus below. Wound sections of
K14-a9 null mice (a, b, and c) or control mice (d, e, and f) were treated with anti-BrdU (a and d), phalloidin (b and e), and Hoechst (c and f). Note decreased
numbers of BrdU-positive (arrow) keratinocytes (marked as ‘‘e’’) in the epithelial tongue over the wound bed (W) in K14-a9 null wounds (panel a) compared
with control mice wounds (panel d, and quantitative analysis in panel g). The white dotted line represents border between the epidermis and dermis.
Note decreased Ki67 labeling at day 4 in K14-a9 null wounds (h). N¼ 3; scale bar: 50 mm in panel (f), *Po0.005, **Po0.05.
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anti-involucrin, as terminal differentiation markers. At days 7
and 10, we observed decreased staining for loricrin (Figure
6a–h and data not shown) and involucrin (Figure 6n–q and
data not shown) in the stratum granulosum of K14-a9 null
wounds compared with control wounds. Quantitative analy-
sis showed that the loricrin-positive stained area normalized
to the total area of the epidermis was significantly reduced in
K14-a9 null and control wounds (Figure 6m). By day 14, after
wounding, no significant differences in loricrin staining were
observed in K14-a9 and control mice (Figure 6i–l). These
observations suggest that decreased differentiation may not
be a direct outcome of the loss of a9 in the skin, but could be
attributed to decreased proliferation in K14-a9 null mice.
This decreased proliferation negatively impacts the differ-
entiation process; however, the observed delay in differentia-
tion is corrected with more time elapsed after re-
epithelialization.
DISCUSSION
Prompt re-epithelialization of wounds is critical to the
restoration of an effective barrier to prevent wound infection
and dehydration. Epidermal keratinocytes execute efficient
re-epithelialization by integrating complex cellular processes,
including adhesion, migration, proliferation, and differentia-
tion. Integrins, cell surface receptors for extracellular matrix
proteins, are known to participate in all of these cellular
functions in vitro (Sheppard, 1996, 2000; Hynes, 2002,
2004). Yet, the impact of specific b1 integrin heterodimers on
the re-epithelialization process during wound healing re-
mains unclear. Using a LoxP–Cre recombinase system to
introduce an epidermal-specific conditional deletion of the
a9 gene, we evaluated the functional role of epidermal
integrin a9b1 during epidermal wound healing. We report
that the deletion of the a9b1 gene reduces normal
keratinocyte proliferation during re-epithelialization in heal-
ing cutaneous wounds.
Loss of a9b1 integrin disrupts squamous epithelial tissue
homeostasis in the unwounded cornea but not in the skin
The lack of any apparent difference in epidermal proliferation
in the unwounded skin in K14-a9 integrin null mice
suggested that a9b1 was not required for normal epidermal
development. Not surprisingly, the phenotypes of the
uninjured skin observed with our K14-a9b1 null mice were
significantly less pronounced than those observed in skin-
specific knockout of the entire b1 integrin family (Raghavan
et al., 2000; Brakebusch et al., 2002; Grose et al., 2002). The
epithelial cells of control and K14-a9 null cornea and the skin
had similar proliferation indices. Although the loss of integrin
a9b1 caused no apparent difference in the morphologically
or differentiation of epidermal keratinocytes in quiescent
skin, the unwounded corneal epithelium was thinner and the
basal cells flatter than those of control corneas. The overall
corneal thickness was also impacted by the loss of a9b1.
There was no evidence of inflammation or neovasculariza-
tion, suggesting that the corneal epithelium was adherent and
stable. Studies by Chung et al. (1992) showed that the corneal
epithelium differentiates after birth in rodents prior to eyelid
opening at 2 weeks. The corneal epithelium, like the
epidermis, is initially two cell layers thick with flattened
basal cells covered by a periderm layer (Stepp et al., 1995).
Between days 10 and 14 after birth, the basal cells proliferate
and corneal epithelial thickness increases from 2 to 3–5 layers
of cells. At the time of eyelid opening, the corneal epithelial
basal cell transition from flattened to cuboidal to columnar
(Chung et al., 1992). It is unclear why these changes in cell
morphology occur, but they have been postulated to be
induced by the differentiation of the corneal epithelial
basement membrane (Rodrigues et al., 1987). Although
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Figure 5. Poor re-epithelialization in K14-a9 null wounds compared with
control mice. Excisional cutaneous wounds were harvested at intervals of
5 days after wounding. Harvested wounds were oriented with the epidermis
on top and the panniculus carnosus below. Lengths and areas of the migrating
tongues (t) were visualized by K14 (a and c) or phalloidin (b and d) staining.
Graph represents average length of the wound edge (e) and the area
covered by the neoepidermis (f). No statistically significant difference was
observed in the length of the migrating tongue, whereas reduced area was
covered by the tongue of K14-a9 null wound (*Po0.001). The graph (g)
shows no difference in the distance traveled by the keratinocytes to cover the
wound in microns. N¼ 6; scale bar: 50mm.
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a3b1 integrin and laminin 332 are both expressed before
birth by the corneal epithelial cells (Stepp et al., 1995; Stepp,
1999), integrin a6b4 is first expressed after birth beginning
between days 10 and 14. Interestingly, integrin a9b1 is
expressed by all the basal cells on the mouse cornea
beginning at 10 days after birth between day 10 and day
21, as the ocular surface matures, integrin a9b1 becomes
restricted to a subpopulation of basal cells at the limbus
(Stepp et al., 1995), where it is retained in cells that have
been shown to be early transiently amplifying cells (Pajoo-
hesh-Ganji and Stepp, 2005). The basal cells of the K14-a9
null mouse appear to have not undergone the cell shape and
differentiation changes typical of a fully mature ocular
surface, suggesting that integrin a9 is required for those
important events.
The stem cells that maintain the ocular surface express a9
integrin as they leave their niche (Pajoohesh-Ganji et al.,
2006). The expression of a9b1 in the early transiently
amplifying cells has been hypothesized to be required for
the departure of stem cell progeny from the niche to
repopulate the ocular surface during normal tissue home-
ostasis and turnover (Pajoohesh-Ganji and Stepp, 2005).
Thus, the reduced numbers of cells covering the cornea in the
a9b1 null mouse could also result from immigration of fewer
early transiently amplifying cells to the cornea from the
limbus. We found no evidence for corneal epithelial stem cell
deficiency on the unwounded corneas from the K14-a9 null
mice (unpublished data). It remains to be determined whether
inflicting wounds in the adult corneas, in vivo, resulted in
a9b1-dependent stem cell deficiency.
Lack of integrin a9 in epidermal keratinocytes reduces
proliferation after injury
Despite the lack of an apparent difference in epidermal
proliferation in normal, unwounded skin of K14-a9 null
mice, after injury, we observed a markedly reduced level of
proliferation in keratinocytes residing just behind the
pioneering migrating cells of the neoepidermis in K14-a9
null mice. Conditional knockout of b1 integrins in epidermal
keratinocytes resulted in reduced proliferation in isolated
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Figure 6. Terminal differentiation is delayed in K14-a9 null mice compared with control mice. Excisional cutaneous wounds were harvested at 10 and 14
(a–h, i–l, and n–q) days after wounding. Harvested wounds were oriented with the epidermis on top and the panniculus carnosus below. Wound sections of
K14-a9 null mice (a–d, i, j, n, and o) or control mice (e–h, k, l, p, and q) were treated with rabbit anti-loricrin (Lo) antibodies (a, e, i, and k), K14 on a
consecutive section (c and g for panel a and e), involucrin (Inv) antibodies (n and p), or phalloidin (b, d, f, h, j, l, o, and q). Note reduced staining for Lo or Inv
in the stratum granulosum layer of the epidermis of K14-a9 null and control wound at day 10. The graph (m) shows reduced mean fluorescent area covered with
Lo staining normalized to K14 staining in K14-a9 null compared with control wounds (*Po0.02). N¼3; scale bar: 50 mm.
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keratinocytes (Fassler and Meyer, 1995; Raghavan et al.,
2000; Grose et al., 2002). We did not observe any
compensatory upregulation of other b1 integrins, including
a3b1 in the keratinocytes in K14-a9 null mice (data not
shown).
Our data from studies on K14-a9 null mice are distinct
from the data obtained with K5-b1 null mice. No difference
in the percentage of BrdU-positive interfollicular epidermal
keratinocytes at 1 or 5 days after wounding was observed in
K5-b1 null mice (Grose et al., 2002). This discrepancy in
wound keratinocyte proliferation could be because of the use
of different keratin promoters to mediate excision of either
integrin a9 (K14 promoter) or b1 (K5 promoter) from
keratinocytes. Others have reaffirmed the role of b1 family
integrins in keratinocyte proliferation. By grafting a3b1
integrin null skin onto the back of nude mice, Conti et al.
(2003) reported that integrin a3b1 is the b1 family integrin
that regulates follicular proliferation. Because hair follicles
are a source of keratinocytes during wound healing, our
observations suggest that the decreased proliferation ob-
served in the wound keratinocytes in the K14-a9 null skin
would likely have been more pronounced if it were not for
the contribution of follicular keratinocytes for which pro-
liferation was unaffected by a9b1 deletion. Taken together
with our data, current research suggests that in addition to
a9b1 integrin, there are other integrins within the b1 family
that regulate interfollicular epidermal and corneal epithelial
cell proliferation. Growth factors, such as keratinocyte
growth factor, along with integrins, are critical regulators of
wound epidermal proliferation (Werner et al., 1994). Our
results support a mechanism in which integrin a9b1 exerts
overall regulatory control to permit growth factor-mediated
proliferation to proceed optimally.
K14-a9 null cutaneous wounds re-epithelialize poorly
Although we observed a significant decrease in keratinocyte
proliferation in healing wounds, the rates of re-epithelializa-
tion remained identical in K14-a9 null wounds compared
with control wounds. Interestingly, the length of the migrating
keratinocyte ‘‘tongue’’ was comparable in either genotype,
whereas the total area in a wound section of the ‘‘neoepi-
dermis’’ was significantly reduced in K14-a9 null wounds
compared with control wounds. This difference in area,
manifested as diminished thickness in the conditional null, is
most likely attributable to the reduced numbers of migrating
keratinocytes, as a downstream consequence of the dimin-
ished proliferation observed in the K14-a9 null mice. One
outcome of this decreased epidermal thickness is a reduction
in the ‘‘quality’’ of re-epithelialization. We speculate that the
importance of closing the wound promptly takes precedence
over other functions such as differentiation; the mutant
keratinocytes compensate for decreased proliferation by
reducing epidermal thickness to facilitate prompt wound
coverage. One consequence of the diminished proliferation
and epidermal thickness that we observed is that terminal
differentiation is delayed in K14-a9 null wounds compared
with control mice. Rather than being a direct outcome of the
loss of integrin a9, we speculate that this is a consequence of
delayed or poor wound healing. Wounding activates
keratinocytes and forces them to leave their normal
differentiation program and to undergo proliferation and
migration to heal the wound (Coulombe, 2003). In our
system, using K14-a9 null mice, we speculate that keratino-
cytes remain in this activated state for longer intervals
resulting in a delayed differentiation program. However,
differentiation is not completely impaired and eventually
keratinocytes emerge from the ‘‘activated’’ state and differ-
entiate normally. Several b1 integrins have been shown to be
crucial for keratinocyte migration, both in vitro and in vivo,
and integrin a9b1 has been reported to promote migration
through a mechanism involving spermidine NI acetyl
transferase in vitro (Raghavan et al., 2000; Young et al.,
2001; Grose et al., 2002; Chen et al., 2004; Choma et al.,
2004; Frank and Carter, 2004). Because we observed no
significant differences in the rate of migration of wound edge
keratinocytes in K14-a9 null wounds, we speculate that other
integrins subserve this regulatory function. We find that a9b1
levels decrease precipitously and permanently when epider-
mal or corneal keratinocytes are explanted into culture. To
date, neither we have been unable to prevent this loss of a9b1
by a variety of culture techniques nor have been able to
restore expression by reconstituting cultured keratinoctyes
into skin, in vitro (unpublished data). Further testing of the
mechanisms through which a9b1 regulates keratinocyte
proliferation and migration awaits stable transduction of
a9b1 into primary keratinocytes.
Our observations indicate that although integrin a9b1 is
required for normal differentiation of the corneal epithelium,
it is not required for normal development of the epidermis.
However, after injury to skin, integrin a9b1 is required for
optimal keratinocyte proliferation and in the absence of
integrin a9b1, a compromised form of re-epithelialization
occurs causing a temporary delay in differentiation. Our data
provide important clues about the functions of a9b1 integrin
both in the differentiating corneal epithelium and in healing
cutaneous wounds.
MATERIALS AND METHODS
Integrin a9 conditional knockout mice
Integrin a9 genomic DNA was amplified by three PCR reactions
from mouse 129/SVJae genomic DNA. Recombinant homology
sequences left arm, right arm, and exon 8 are from three primer pairs
(for sequences see Table S1). Three PCR products were subcloned
into the pJB1 (Chen et al., 2006) vector to generate the construct
shown in Figure 1a. The targeting construct was linearized with NotI
and electroporated into RF8 embryonic stem (ES) cells (provided by
Robert V. Farese, Gladstone Institute of Cardiovascular Disease).
Genomic DNA isolated from 400 G418-resistant ES cell colonies
was analyzed by Southern blotting. Two correctly targeted ES cell
clones were identified and injected into blastocysts to generate
chimeras and giving rise to two independent lines. Chimeras were
mated to C57BL/6 females to obtain germline transmission. Neo
selection markers were removed by recombinant between two Flp
recombinase target (FRT) sites in Flpe transgenic mice to generate
integrin a9fl/fl mice. Offspring obtained from mating integrin a9fl/fl
mice with a9 þ /; K14 Creþ / mice were screened for the presence
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of the floxed, wt allele, and/or Cre by PCR analysis of tail DNA with
a9 and Cre primers (for sequences see Table S1).
Wounds
Punch biopsies (4mm diameter) were made in the flanks of female
adult mice (B5–6 weeks old), as described previously (Brown et al.,
1992, 1993). Wounds were harvested at various intervals, embedded
in OCT (Electron Microscopy Sciences, Washington, PA) and frozen
immediately. In some instances, tissues were fixed immediately after
biopsy either in 4% paraformaldehyde and transferred to 70%
ethanol or in K2 buffer (Brown et al., 1992, 1993) and transferred to
sodium cacodylate buffer. All procedures for animal care and
handling had the approval of the relevant Institutional Animal Care
and Use Committee.
Immunohistochemistry
Cryostat sections from mouse (10mm) were placed on poly-lysine-
coated slides and rinsed in phosphate-buffered saline (PBS) to remove
OCT. Sections treated with either rabbit anti-Ki67 antigen (Vector
Labs, Berlingame, CA) or sheep anti-BrdU antibodies (BioDesign,
Carmel, NY) were post-fixed in 3.7% formaldehyde. Unfixed sections
were used for rabbit anti-loricrin (Covance, Berkeley, CA), rabbit anti-
involucrin (Covance), rabbit anti-a9 (Stepp and Zhu, 1997), and rabbit
anti-K14 antibodies (Covance). Tissue sections were blocked with 5%
non-fat milk, 10% heat-inactivated goat serum, and 0.02% Tween 20
in PBS for 1 hour followed successively by diluted primary antibodies,
wash buffer (0.02% Tween 20 in PBS), appropriate fluorescent
secondary IgG in a solution that included phalloidin Alexa 594
(Molecular Probes, Eugene, OR) and Hoechst. Tissues pre-fixed in 4%
paraformaldehyde and sectioned 5mm thick were used for hematox-
ylin and eosin staining (services were provided by Mass Histology,
Worchester, MA). Tissue for 1mm sections was fixed in K2 buffer
embedded in plastic, sectioned, and stained with Giemsa staining.
Photographs were taken under either bright field or epifluorescence
illumination on a Nikon Eclipse 80i using a SPOT camera (Diagnostic
Instruments, Sterling Heights, MI), SPOT and Metaview software were
used for quantitative analysis.
Immunofluorescent labeling and confocal microscopy
Flat mounts of whole corneas were processed and used as described
previously (Pajoohesh-Ganji et al., 2004). The rat anti-mouse E-
cadherin monoclonal ECCD-2 (Zymed, Eugene, OR; now marketed
as Invitrogen 13-1900) was used. Images were acquired using a Bio-
Rad confocal microscope and three-dimensional images were
prepared and analyzed using the three-dimensional constructor
module 5.1 of Image Pro Plus version 6.2 from Media Cybernetics.
Sections of 1mm thickness were acquired throughout the cornea and
corneas typically are 40–60 mm thick. To measure the height of the
basal cell nuclei, 10 individual nuclei were visualized in sequential
layers starting at the basal aspect at the basement membrane zone;
P-values were less than 0.05 using the two-tailed Student’s t-test.
BrdU labeling
Mice were injected with BrdU intraperitoneally at a concentration of
50mg per kg body weight of mice 4 hours prior to harvest. For
detection of BrdU, cryostat sections (10 mm) were placed on poly-
lysine-coated slides and rinsed in PBS to remove OCT. Tissues were
fixed in 3.7% formaldehyde for 10minutes, washed in wash buffer
for 10minutes, and permeabilized with 0.5% Triton-X for 5minutes,
followed by wash buffer for 10minutes. Tissue sections were
blocked with 5% non-fat milk in 0.02% Tween 20 in PBS, and
subjected to immunostaining (as described above).
Quantitative analysis of proliferation
For corneas, eyes were fixed in methanol, corneas dissected away
from the rest of the eye, and BrdU labeling was performed using
Roche’s in situ Cell Proliferation kit with modifications as described
by Pajoohesh-Ganji et al. (2006). Six control and seven conditional
K14-a9 null mouse corneas were assessed with four fields quantified
per cornea. Therefore, no fewer than three mice were used for each
analysis. Statistical significance was determined using the Student t-
test and P-values were less than 0.05.
Skin proliferation was analyzed using two different markers, Ki67
or BrdU incorporation. In each field either Ki67- or BrdU-positive
keratinocytes were counted in the basal layer and a layer above it
within a fixed area marked by a box, followed by counting the total
number of nuclei in the same area either manually or with Metaview
software. For each section, multiple fields were counted and the same
area was used for every field and section. The percentage ratio of Ki67-
or BrdU-positive/total number of nuclei was calculated and plotted on
the graph. Statistical analysis was determined using the Student t-test.
Wound closure analysis
Harvested wounds oriented with the stratum corneum on top and
panniculus carnosus at the bottom were sectioned vertically (10 mm
thick). Each section was numbered and the first section showing the
wound edges unmerged was marked as (A). As the wound was
sectioned deeper, the first section observed with two wound edges
merged was marked as (B). Both sections A and B were stained with
rabbit anti-K14 antibody to confirm unmerged or merged wound
edges, respectively. To calculate the percentage of wound closure,
the section number with wound edge merged (B) minus the section
number with the wound edges unmerged (A) was determined
yielding the total number of sections with no merged wound edges
(NR). This number was multiplied by 10 (as each section is 10 mm
thick). The resulting number (R) is the total distance with no wound
edge merged in micrometers. Because the initial wound was
4,000mm in diameter, subtracting R from 4,000 mm gives the total
distance migrated by the keratinocytes to close the wound (M). The
percentage of average M values was plotted on the graph.
Area and length measurements
Section ‘A’ (as described above) was used for epithelial tongue area
and length measurements. The method was used as described
previously (Tscharntke et al., 2007) using Spot imaging analysis
software. Statistical analysis was determined using the Student
t-test.
Quantitative analysis of differentiation
Images of 10-day wound sections from either K14-a9 null or control
wounds stained for loricrin and consecutive section for K14 were
used to calculate the mean fluorescent area. Total area covered
by loricrin staining was normalized to total area of the epidermis
(K14-stained sections were used to determine the total area of
the epidermis). The area was calculated using Image Pro Analysis
software. Student’s t-test was used for statistical analysis.
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